A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003
Clinical trial NCT07623798 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07623798
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-05
- Primary completion
- 2029-05-31
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.